Abstract The existence of the EUROCARE database now makes it possible to compare population-based survival for childhood melanoma in different European populations. The database contains verified information, including histological data, from cancer registries in 17 European countries, and as such it represents a particularly important source of survival information on a very rare cancer like childhood melanoma. The aim of the present paper was to describe survival in children with melanoma (MM), by sex, age and subsite, diagnosed during the period 1978--1989, using analysis of the data of the European pool of cases. Five year-survival for childhood MM diagnosed in 1978--1989 in Europe, is relatively good (80%; 95% confidence interval (CI) ...
Abstract The aim of this study was to provide a comparative description of geographical variations a...
The aim of this study was to provide a comparative description of geographical variations and time t...
BACKGROUND: Survival and cure rates for childhood cancers in Europe have greatly improved over the ...
The existence of the EUROCARE database now makes it possible to compare population-based survival fo...
Abstract Patterns and trends of melanoma and skin carcinoma incidence and survival of European child...
Background: Melanoma is rare in the first two decades of life. Trends in incidence differ across cou...
Abstract This paper describes the database of children with cancer in the EUROCARE study and the met...
Melanoma in children is rare. Nevertheless, it is imperative that clinicians be aware that melanoma ...
Abstract PURPOSE: EUROCARE collected data from population-based cancer registries in 20 European cou...
In most developed countries, malignant lymphomas account for 10--15% of all cancers occurring among ...
This special issue of the European Journal of Cancer (EJC) comprises a set of 16 papers which analys...
Abstract Other articles in this issue of the European Journal of Cancer have described population-ba...
The aim of this study was to provide a comparative description of geographical variations and time t...
OBJECTIVE: To describe a series of cutaneous melanoma in children collected by the Italian Rare Tumo...
Background: EUROCARE-3 collected data from 45 population-based cancer registries in 20 countries on ...
Abstract The aim of this study was to provide a comparative description of geographical variations a...
The aim of this study was to provide a comparative description of geographical variations and time t...
BACKGROUND: Survival and cure rates for childhood cancers in Europe have greatly improved over the ...
The existence of the EUROCARE database now makes it possible to compare population-based survival fo...
Abstract Patterns and trends of melanoma and skin carcinoma incidence and survival of European child...
Background: Melanoma is rare in the first two decades of life. Trends in incidence differ across cou...
Abstract This paper describes the database of children with cancer in the EUROCARE study and the met...
Melanoma in children is rare. Nevertheless, it is imperative that clinicians be aware that melanoma ...
Abstract PURPOSE: EUROCARE collected data from population-based cancer registries in 20 European cou...
In most developed countries, malignant lymphomas account for 10--15% of all cancers occurring among ...
This special issue of the European Journal of Cancer (EJC) comprises a set of 16 papers which analys...
Abstract Other articles in this issue of the European Journal of Cancer have described population-ba...
The aim of this study was to provide a comparative description of geographical variations and time t...
OBJECTIVE: To describe a series of cutaneous melanoma in children collected by the Italian Rare Tumo...
Background: EUROCARE-3 collected data from 45 population-based cancer registries in 20 countries on ...
Abstract The aim of this study was to provide a comparative description of geographical variations a...
The aim of this study was to provide a comparative description of geographical variations and time t...
BACKGROUND: Survival and cure rates for childhood cancers in Europe have greatly improved over the ...